Featured
Last news
Two decades later, impacts from Indonesia mud volcano linger
Harwati clasped her hands and offered a prayer on the edge of a sludge lake on the Indonesian island of Java, as dozen of residents gathered to mark two decades since mud volcano eruptions began displacing thousands.
Australian researchers teach brain cells to play 'Doom'
Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the nineties shooter "Doom" and say they are just scratching the surface of what the neurons could be capable of doing.
'Totally hooked': Hong Kong targets claw machine addiction
Claw machine lover Neiki Lee carefully lowers the metal jaws of a crane with a joystick into a pool of prizes, only to have the small toy slip from its clutches again and again.
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?
"One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is responsible drug policy?" stated Duane Boise, CEO MMJ International Holdings.Anne Milgram is gone, and most of the architects of pharmaceutical obstruction have retired. As the June 29 rescheduling hearing approaches, the DEA must answer for a decade of systematic patient abandonment.
Trump admin walks back recent Green Card announcement
The Trump administration has walked back its announcement that non-citizens seeking permanent US residency, commonly called a Green Card, would need to return to their home country to apply, The New York Times reported.
Heatwave makes conditions 'inhumane', say inmates at overcrowded Paris suburb prison
A damp towel hangs from a barred window, a fan churns the muggy air: Inmates at the overcrowded Villepinte prison outside Paris say enduring a heatwave that has stifled France in recent days in cramped cells is "inhumane".
Canadian poison seller pleads guilty to aiding suicides, avoids murder trial
The Canadian man who sold poison to distressed people worldwide pleaded guilty on Friday to 14 counts of aiding suicide but avoided a murder trial, an outcome one victim's father branded "a disgrace."
MMJ ET AL PREPARES APPEAL CMS HEMP PROGRAM: How Can a Company With a Manufactured Pharmaceutical Soft Gel Be Told It Has "No Product"?
JUDGE McFADDEN SAID MMJ HAS "NO PRODUCT." THE RECORD SAYS OTHERWISE.How Can a Company With FDA INDs, Orphan Drug Designation, Manufactured Soft gel Capsules, and Reproducible Chemistry Be Described as Having "No Product"? asked Duane Boise, CEO MMJ International Holdings.
Canadian poison seller pleads guilty to aiding suicides
The Canadian man who helped scores of people worldwide kill themselves by selling them poison pleaded guilty on Friday to 14 counts of aiding suicide, as prosecutors said they will withdraw murder charges.
German ex-minister faces perjury charges over failed car toll plan
A former German transport minister faces a perjury trial related to a failed scheme to charge foreign motorists highway tolls, a debacle that cost the government hundreds of millions of euros.
Blue Origin rocket explodes on launch pad
Blue Origin's New Glenn rocket exploded during a test Thursday on the launch pad in Cape Canaveral, Florida, though officials said no injuries were reported from the incident.
Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC0, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium longevity brand, announces a proposed non-brokered private placement financing (the "Private Placement"), consisting of the issuance of an aggregate of up to 2,500,000 units of the Company (each, a "Unit"), at a price of $1.00 per Unit for aggregate gross proceeds of up to $2,500,000.
The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
The Company reported a record quarterly billed revenue of $12.5M (CAD $17.8M) in Q1 2026, representing a YoY increase of 17% from Q1 2025.The Company achieved positive EBITDA of $0.3M (CAD $0.4M) and Adjusted EBITDA of $0.5M (CAD $0.7M) in Q1 2026, despite incremental costs associated with the ramp-up of its new manufacturing facility.The Company completed the retrofit and commenced operations at its newly leased 154,000-square-foot manufacturing facility in the southwest suburbs of Chicago, expanding production capacity for future growth.The Company completed a $3.0M ($4.3M) private placement in January 2026, strengthening its balance sheet and supporting its expansion strategy.
Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings
Proprietary qualitative model evaluates payer technology, managed services, BPaaS, analytics, AI, cybersecurity, interoperability, clinical operations, administrative operations, and transformation partners through verified user experience and operational evidence
Dr. Ran Rubinstein Brings BioRePeel to Newburgh, NY and Montvale, NJ
Dr. Ran Rubinstein introduces BioRePeel to both New York and New Jersey practices as demand grows for no-downtime skin rejuvenation treatments.
NextBoat Inc. Completes Corporate Rebrand and Begins Trading Under "NXB" on NYSE American
Company accelerates evolution into AI-powered platform transforming how boats are bought and sold
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
FORT LAUDERDALE, FL / ACCESS Newswire / May 29, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,624,066 B2, titled "Compounds and Methods for Treatment of Coronavirus Infection." The newly granted patent protects Sunshine Biopharma's proprietary therapeutic compounds designed to inhibit coronavirus replication.
American Rebel Light Beer Powers into the NHRA Potomac Nationals this Weekend (May 29-31, 2026) with Tony Stewart Racing, Matt Hagan's Funny Car, and John Hall's Pro Stock Motorcycle
NHRA Potomac Nationals Provide a Powerful Platform for American Rebel Light Beer's Nationwide Expansion Strategy and Multi-Class Racing PresenceMulti-Class NHRA Platform Delivers Coast-to-Coast Broadcast Reach and Trackside Impact for American Rebel Light - America's Patriotic Beer BrandAmerican Rebel-Branded Sponsorship with Tony Stewart Racing, Matt Hagan, Leah Pruett, and John Hall Amplifies National Brand Momentum Across FOX, FS1, and NHRA.tv While Connecting with NHRA's Loyal, Values-Driven Fan Base
MMJ International Holdings Files Formal Challenge To DEA Marijuana Rescheduling As Constitutional, Treaty, And Pharmaceutical Questions Collide
"After Eight Years, Millions invested, FDA INDs, Orphan Drug Designation, DEA Inspections, and a Completed Federal Investigation, MMJ Demands the Government Explain Why Companies That Followed Federal Law Were Left Behind" asked Duane Boise, CEO MMJ International Holdings.
Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Grant of Options and Extension of Warrant Term
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 29
LONDON, UK / ACCESS Newswire / May 29, 2026 / The Company announces that on 28 May 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
US labels two Brazilian crime groups as terrorist organizations
The United States on Thursday designated two well-known Brazilian crime groups, the so-called Red Command (CV) and First Capital Command (PCC), as terrorist organizations, despite opposition from Brasilia.
Netflix criticises German plan to make streamers invest more locally
Netflix and other streaming services on Thursday criticised a German plan requiring platforms to reinvest a share of locally generated revenue as part of efforts to support domestic film production.
Attacker wounds three at Swiss train station with 'bladed weapon'
A man reportedly shouting "Allahu akbar!" injured three people with a bladed weapon at a train station near Zurich on Thursday, before being arrested, Swiss police said.
France inches towards symbolic repealing of slavery legislation
Lawmakers were moved to tears in parliament Thursday as France inched towards repealing outdated legislation that defines people enslaved in its colonies as "moveable goods", in a symbolic move as the country grapples with its colonial legacy.
Italian police seize $232 mn in late mafia boss's assets
Italy said Thursday it was seizing more than 200 million euros ($232 million) in assets belonging to late Mafia boss Matteo Messina Denaro derived from drug trafficking and reinvested in Europe and beyond.
EU fines Temu 200 mn euros over illegal products
The EU slapped a 200-million-euro ($232 million) fine on Chinese-owned online retailer Temu on Thursday for allowing the sale of illegal products, including dangerous baby toys and defective chargers.
Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform
News Release Highlights:Vanta enters into strategic operating and infrastructure agreement supporting the planned launch of a U.S.-focused peptide therapy and longevity platform leveraging telehealth-enabled commercialization infrastructure, FDA-registered 503A and 503B compounding pharmacy relationships, peptide manufacturing and fulfillment capabilities, and compliant merchant processing infrastructure designed to support scalable online and in-person payment capabilities.Contemplated U.S. peptide therapy platform intended to operate as an integrated telehealth-enabled wellness and longevity ecosystem supporting scalable digital patient acquisition, clinician consultations, prescription authorization workflows, pharmacy fulfillment, subscription continuity, customer retention, and recurring subscription-oriented revenue generation through a capital-efficient downstream commercialization strategy.Vanta advancing integrated consumer health sciences and longevity ecosystem combining U.S.-focused peptide therapy, nutraceutical, and premium hydration integrated product portfolio positioned to capitalize on growing consumer demand for preventative wellness and healthspan extension initiatives across metabolic optimization, recovery, performance optimization, and healthy aging categories.
American Rebel CEO Andy Ross Appeared Last Night on Dr. Drew, Defending American Freedoms and Celebrating the Spirit of the American Dream
American Rebel Holdings (OTC:AREB) CEO Andy Ross took America's Patriotic Brand™ to Dr. Drew's national audience yesterday - discussing the Second Amendment, Stand Your Ground principles, patriotism, and his new Patriotic Anthem celebrating 250 years of America "Hold my Beer", with the full segment now available to watch on replay
Ownia Collection Launches Summer 2026 Edit: The New Definition of Ultra-Luxury Traveling with Purpose
As 95% of next-gen luxury travelers demand verified eco-credentials, Ownia's curated portfolio proves that ultra-premium hospitality and strict conservation accountability are inseparable.
Pharmacy Podcast Network Recognized Among RXinsider's Pharmacy500 Best Businesses Inside Pharmacy for Third Consecutive Year
Three-year Pharmacy500 recognition highlights Pharmacy Podcast Network's unique role in turning pharmacy media, public relations, podcasting, and targeted content distribution into business-development opportunities across the pharmacy profession.
LogoTags, America's Leading Custom Race Medal and Challenge Coin Company, Sponsors Clemson Race
LogoTags, Trusted Fifth-Generation Family-Owned U.S. Manufacturer, Supports the 2026 South Carolina Tri Series with Premium Custom Challenge Coin